FDA eyes issuing an advisory against the use of Pfizer's COVID vaccine for old and very frail individuals
By Noreen Jazul
The Food and Drug Administration (FDA) said it is eyeing to release an advisory against the use of Pfizer-BioNTech's COVID-19 vaccine for “very old and very frail” individuals.

FDA Director-General Rolando Enrique Domingo made the statement following reports that 33 elderly people died in Norway after receiving their first doses of the vaccine.
Thirteen out of the 33 cases were “frail and have serious illnesses,” according to Norwegian Institute of Public Health Director Camilla Stoltenberg.
“Magkakaroon lang po siguro ng revisions at advisory against the use of yung vaccine on very old at tsaka yung very fragile, ‘yun pong mahihina na (We’ll probably make revisions and an advisory against the use of the vaccine on very old and very fragile persons, those who are already weak),” Domingo told DZMM Teleradyo on Tuesday.
As to the guidelines for the vaccine’s use, Domingo said changes have yet to be made since the post-vaccination deaths in Norway are still under investigation.
Norway has earlier said that no link has been established yet between the post-immunization deaths and the Pfizer-BioNTech's COVID-19 vaccine.
However, doctors in Norway were advised to consider the overall health of the most frail before giving them a jab.
Pfizer’s vaccine has already been authorized for emergency use in the country. (With a report from Agence France-Presse)